Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolomics biomarkers of frailty in elderly breast cancer patients.
Corona G, Polesel J, Fratino L, Miolo G, Rizzolio F, Crivellari D, Addobbati R, Cervo S, Toffoli G. Corona G, et al. Among authors: crivellari d. J Cell Physiol. 2014 Jul;229(7):898-902. doi: 10.1002/jcp.24520. J Cell Physiol. 2014. PMID: 24659054
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.
Miolo G, Muraro E, Caruso D, Crivellari D, Ash A, Scalone S, Lombardi D, Rizzolio F, Giordano A, Corona G. Miolo G, et al. Among authors: crivellari d. Oncotarget. 2016 Jun 28;7(26):39809-39822. doi: 10.18632/oncotarget.9489. Oncotarget. 2016. PMID: 27223427 Free PMC article.
Special populations: elderly patients.
Crivellari D, Fratino L. Crivellari D, et al. Cancer Treat Res. 2009;151:299-315. doi: 10.1007/978-0-387-75115-3_19. Cancer Treat Res. 2009. PMID: 19593520 Review. No abstract available.
Therapeutic management of breast cancer in the elderly.
Spazzapan S, Crivellari D, Bedard P, Lombardi D, Miolo G, Scalone S, Veronesi A. Spazzapan S, et al. Among authors: crivellari d. Expert Opin Pharmacother. 2011 Apr;12(6):945-60. doi: 10.1517/14656566.2011.540570. Epub 2011 Feb 16. Expert Opin Pharmacother. 2011. PMID: 21323593 Review.
Target therapy in elderly breast cancer patients.
Carli P, Turchet E, Quitadamo D, Spada A, Miolo G, Lamaj E, Spazzapan S, Di Lauro V, Dolcetti R, Veronesi A, Crivellari D. Carli P, et al. Among authors: crivellari d. Crit Rev Oncol Hematol. 2012 Sep;83(3):422-31. doi: 10.1016/j.critrevonc.2011.12.004. Epub 2012 Jan 17. Crit Rev Oncol Hematol. 2012. PMID: 22257652 Review.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R. Muraro E, et al. Among authors: crivellari d. Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060. Breast Cancer Res. 2011. PMID: 22112244 Free PMC article.
152 results